Global Biological Treatment Equipment Market Strategic Research Report
By Type: Activated Sludge System, Biofilm Reactor System, Anaerobic Digestion System, Aerobic Treatment System
By Application: Municipal, Food and Beverage, Pharmaceutical, Chemical, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Veolia (FR), Evoqua Water Technologies (US), Condorchem Envitech (ES), Xylem (US), Lakeside Equipment Corporation (US), Ovivo Water Inc (CA), ALFA LAVAL (SE), Aqua-Aerobic Systems (US), MITA Water Technologies (IT), Kurita Water Industries (JP), WesTech Engineering, LLC (US), Krones AG (DE), Shanghai Ritai Medicine Equipment Project Co (CN)
Visão geral
Scope of the Report
The global Biological Treatment Equipment market size is predicted to grow from US$ 6,198 million in 2025 to US$ 9,487 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.
Biological Treatment Equipment refers to engineered systems and machinery that use microorganisms such as bacteria, fungi, or algae to degrade, transform, or remove organic pollutants, nutrients, and contaminants from wastewater, sludge, exhaust gas, or solid waste through aerobic or anaerobic biochemical processes, commonly applied in environmental protection, municipal sewage treatment, industrial effluent management, and waste-to-resource recovery systems.
The biological treatment equipment industry chain begins upstream with raw material suppliers providing steel, polymers, membranes, aeration components, sensors, and microbial strains, along with engineering design inputs and automation control systems, followed by midstream manufacturers that design, assemble, and integrate treatment units such as reactors, bioreactors, aeration tanks, and membrane modules with electrical and control systems, and extends downstream to end users including municipal wastewater plants, industrial facilities, and environmental service operators who install and operate these systems for wastewater purification, sludge reduction, and pollution control, supported by maintenance services, regulatory compliance, and performance monitoring systems across global environmental infrastructure networks.
Global biological treatment equipment projects under construction and planning include large-scale municipal wastewater treatment plant expansions in Asia and the Middle East, industrial wastewater upgrading projects in chemical, textile, and food processing industries in China and India, advanced membrane bioreactor installations in Europe for urban water reuse, anaerobic digestion facilities in North America for sludge-to-energy conversion, and decentralized wastewater treatment systems in developing regions, alongside smart water infrastructure upgrades integrating digital monitoring and automation, driven by stricter environmental regulations, urbanization, and circular economy initiatives promoting water recycling and sustainable waste management practices across global infrastructure investments.
2025 Global Market Average Gross Profit Margin: 28%.
The biological treatment equipment market is experiencing stable long-term growth driven by increasing global demand for wastewater treatment, stricter environmental regulations, and rising industrial pollution control requirements across both developed and emerging economies. Municipal infrastructure upgrades remain a major growth driver, particularly in rapidly urbanizing regions where water scarcity and pollution concerns are accelerating investment in advanced treatment systems. Industrial sectors such as chemicals, food and beverage, pharmaceuticals, and textiles are increasingly adopting biological treatment technologies to comply with discharge standards and improve sustainability performance.
Regionally, Asia-Pacific dominates the market due to large-scale infrastructure development, population density, and government-led environmental initiatives, while North America and Europe focus on technology upgrades, energy-efficient systems, and wastewater reuse applications. Emerging markets in Latin America, the Middle East, and Africa are gradually expanding adoption due to increasing industrialization and public health concerns.
Market opportunities are strongly linked to trends in water reuse, zero liquid discharge systems, and integration of biological treatment with digital monitoring and AI-based optimization systems. However, risks include high capital investment requirements, operational complexity, sensitivity of biological processes to environmental conditions, and fluctuating policy enforcement in certain regions. Technological advancement in membrane bioreactors, anaerobic digestion, and hybrid biological-physical systems is reshaping industry standards and improving treatment efficiency.
Competitive characteristics of the market are moderately fragmented, with global engineering firms, specialized environmental equipment manufacturers, and regional integrators competing on system efficiency, lifecycle cost, and technological innovation. Leading companies differentiate through energy-efficient designs, automation capabilities, and integrated service offerings, while smaller players compete through localized solutions and cost advantages. Overall, the market is shifting toward intelligent, modular, and resource-recovery-oriented biological treatment systems aligned with global sustainability and circular economy goals.
This report presents a comprehensive overview of the global Biological Treatment Equipment market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Activated Sludge System
- Biofilm Reactor System
- Anaerobic Digestion System
- Aerobic Treatment System
Segment by Reactor Configuration Type
- Moving Bed
- Fixed Bed
Segment by Oxygen Demand Range
- Dissolved Oxygen (DO) Range: <0.5 mg/L
- Dissolved Oxygen (DO) Range: 0.5 – 1.5 mg/L
- Dissolved Oxygen (DO) Range: >1.5 mg/L
Segment by Application
- Municipal
- Food and Beverage
- Pharmaceutical
- Chemical
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Biological Treatment Equipment market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Municipal, Food and Beverage, Pharmaceutical evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Biological Treatment Equipment Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Activated Sludge System
- 3.1.3 Biofilm Reactor System
- 3.1.4 Anaerobic Digestion System
- 3.1.5 Aerobic Treatment System
- 3.1.6 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Municipal
- 4.1.3 Food and Beverage
- 4.1.4 Pharmaceutical
- 4.1.5 Chemical
- 4.1.6 Others
- 4.1.7 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Veolia (FR)
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Evoqua Water Technologies (US)
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Condorchem Envitech (ES)
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Xylem (US)
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Lakeside Equipment Corporation (US)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Ovivo Water Inc (CA)
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 ALFA LAVAL (SE)
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Aqua-Aerobic Systems (US)
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 MITA Water Technologies (IT)
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Kurita Water Industries (JP)
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 WesTech Engineering, LLC (US)
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Krones AG (DE)
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Shanghai Ritai Medicine Equipment Project Co (CN)
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the current global Biological Treatment Equipment market size?
What growth rate is expected for the Biological Treatment Equipment market through 2032?
How is Biological Treatment Equipment defined?
How is the Biological Treatment Equipment market segmented by type?
What are the key applications of Biological Treatment Equipment?
Which companies are profiled in the Biological Treatment Equipment market report?
What geographies does the Biological Treatment Equipment market analysis include?
What are the key demand drivers for Biological Treatment Equipment?
Who should buy the Biological Treatment Equipment market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Biological Treatment Equipment Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Biotechnology & Life Sciences